| 1 | The Health Care General Committee recommends the following: |
| 2 |
|
| 3 | Council/Committee Substitute |
| 4 | Remove the entire bill and insert: |
| 5 | A bill to be entitled |
| 6 | An act relating to routinely recommended childhood |
| 7 | vaccines; requiring the University of Miami, in |
| 8 | conjunction with regional autism centers, to conduct a |
| 9 | study; providing the goal of the study; providing for |
| 10 | consultation with other schools; requiring a report to the |
| 11 | Governor and the Legislature; requiring the Department of |
| 12 | Health to prepare a notice to be displayed in specified |
| 13 | locations where routinely recommended childhood vaccines |
| 14 | are administered to children in a specified age group; |
| 15 | specifying contents of the notice; requiring certain |
| 16 | health care practitioners that administer such vaccines to |
| 17 | post the notice; providing an effective date. |
| 18 |
|
| 19 | Be It Enacted by the Legislature of the State of Florida: |
| 20 |
|
| 21 | Section 1. Autism study.--The University of Miami, in |
| 22 | conjunction with the regional autism centers established under |
| 23 | s. 1004.55, Florida Statutes, shall conduct an autism |
| 24 | epidemiology study and a review of the current published |
| 25 | scientific literature relating to autism. The goal of the study |
| 26 | is to gain a better understanding of the prevalence of autism in |
| 27 | the state; the unique demographic characteristics of the |
| 28 | autistic population; the role that family history plays in the |
| 29 | development of autism; the effect of routinely recommended |
| 30 | childhood vaccines containing the preservative thimerosal, other |
| 31 | environmental exposure to mercury, and exposure to other toxic |
| 32 | chemicals on children; and other factors that may have an impact |
| 33 | on the development of autism in children. The university may |
| 34 | consult with other Florida university medical schools and |
| 35 | colleges or schools of pharmacy in conducting this study. The |
| 36 | university shall submit a report of its findings to the |
| 37 | Governor, the President of the Senate, and the Speaker the House |
| 38 | of Representatives by October 1, 2007. |
| 39 | Section 2. Department of Health; administration of |
| 40 | routinely recommended childhood vaccines; notice.--The |
| 41 | Department of Health shall prepare a notice for display by all |
| 42 | health care practitioners as defined in s. 456.001(4), Florida |
| 43 | Statutes, who administer routinely recommended childhood |
| 44 | vaccines to children under 3 years of age. The notice shall be |
| 45 | written in simple language so that it is easily understandable |
| 46 | by the general population. The notice shall be made available in |
| 47 | both English and Spanish and shall contain, at a minimum: |
| 48 | (1) A statement indicating that childhood vaccines |
| 49 | routinely recommended by health care practitioners may contain |
| 50 | thimerosal, a preservative that contains mercury. |
| 51 | (2) A statement declaring the official position of the |
| 52 | United States Public Health Service on the presence of |
| 53 | thimerosal in routinely recommended childhood vaccines. |
| 54 | (3) The Internet website address of the Department of |
| 55 | Health pertaining to routinely recommended childhood vaccines |
| 56 | and immunizations. |
| 57 | (4) The Internet website addresses of the Centers for |
| 58 | Disease Control and Prevention and the National Institutes of |
| 59 | Health pertaining to the most current scientific information |
| 60 | regarding the use of thimerosal in routinely recommended |
| 61 | childhood vaccines. |
| 62 | Section 3. Notice to the public.--A health care |
| 63 | practitioner as defined in s. 456.001(4), Florida Statutes, who |
| 64 | administers routinely recommended childhood vaccines to children |
| 65 | under 3 years of age shall display in the office or location |
| 66 | where the vaccinations take place a notice prepared by the |
| 67 | Department of Health containing specific information regarding |
| 68 | vaccines pursuant to section 2. The notice shall be displayed in |
| 69 | a location conspicuous to the public or as required by the |
| 70 | department. |
| 71 | Section 4. This act shall take effect January 1, 2007. |